Marshall Wace North America’s Cardiovascular Systems, Inc. CSII Stock Holding History

Marshall Wace North America’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-22,884	Closed	-$899K	–	1672
2020 Q3	$899K	Buy	22,884 +12,948	+130%	+$418K	0.01%	832
2020 Q2	$313K	Buy	+9,936	New	+$371K	﹤0.01%	999
2018 Q3	–	Sell	-168,619	Closed	-$5.45M	–	1484
2018 Q2	$5.45M	Sell	168,619 -156,098	-48%	-$4.3M	0.03%	493
2018 Q1	$7.12M	Sell	324,717 -233,511	-42%	-$5.61M	0.04%	478
2017 Q4	$13.2M	Buy	558,228 +2,563	+0.5%	+$64.6K	0.07%	315
2017 Q3	$15.6M	Buy	555,665 +172,741	+45%	+$5.25M	0.1%	263
2017 Q2	$12.3M	Buy	382,924 +73,513	+24%	+$2.24M	0.09%	277
2017 Q1	$8.66M	Buy	+309,411	New	+$8.22M	0.07%	298
2013 Q4	$3.06M	Buy	+89,107	New	+$2.59M	0.06%	236

Other funds holding CSII

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Marshall Wace North America's CSII Position: Q4 2020 in Review

Marshall Wace North America sold out of Cardiovascular Systems, Inc. (CSII) in Q4 2020, closing a stake of 22,884 shares — an estimated $899K sold.

Marshall Wace North America first reported a position in CSII in Q4 2013 and held it in 9 quarters. The position peaked at $15.6M in Q3 2017. 183 funds tracked by Wall St. Rank hold CSII as of Q4 2020.

Marshall Wace North America reported no remaining Cardiovascular Systems, Inc. position as of Q4 2020 after selling out during the quarter.
Marshall Wace North America sold 22,884 Cardiovascular Systems, Inc. shares in Q4 2020, an estimated $899K.
Marshall Wace North America first reported a position in Cardiovascular Systems, Inc. in Q4 2013 and held it in 9 quarters.
Marshall Wace North America's Cardiovascular Systems, Inc. position peaked at $15.6M in Q3 2017.
183 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q4 2020.

Based on Marshall Wace North America's 13F filing for Q4 2020, filed 16 Feb 2021.